2019 International Congress Archives - Page 130 of 217

Baicalein incorporated nanoliposome disaggregates alpha-synuclein fibrils

F. Aliakbari, D. Morshedi, H. Mohammad-Beigi, D. Otzen (Tehran, Islamic Republic of Iran)
Balance training modulates the concentration of pro- and anti-inflammatory cytokines in the plasma of elder people and PD patients. A pilot study

J. Szymura, J. Kubica, M. Więcek, J. Pera (Krakow, Poland)
Baseline analysis of PROSPECT-M-UK: a longitudinal study of PSP, CBS and MSA

E. Jabbari, J. Woodside, V. Chelban, A. Costantini, N. Holland, N. Leigh, D. Burn, N. Pavese, A. Gerhard, C. Kobylecki, M. Hu, A. Church, J. Rohrer, H. Houlden, J. Rowe, H. Morris (London, United Kingdom)
Baseline hyposmia and RBD symptoms are associated with faster, but differential, cognitive decline at 2 years in the PPMI study

G. Nomikos, J. Xiao, M. Yang, V. Irzhevsky (Cambridge, MA, USA)
BeaT-PD, An Industry-Academic Collaboration to Understand PD Progression in Ashkenazi Jews

N. Giladi, A. Orr-Urtreger, M. Gana-Weisz, A. Thaler, O. Goldstein, M. Lalioti, K. Evans, M. Hutchison, O. Mabrouk, A. Dowling, T. Fox, M. Yang, K. Parekh, E. Even Sapir, D. Ben Baast, M. Artzi, H. Lerman, L. Yachimovich, B. Cohen, S. John, A. Mirelman, J. Cederbaum (Tel Aviv, Israel)
BeatPark: a new wearable device for gait auto-rehabilitation in Parkinson’s disease delivering adapted musical stimulation.

V. Cochen Decock, D. Dotov, L. Damm, MC. Picot, P. Ihalainen, V. Driss, C. Geny, B. Bardy, S. Dalla Bella (Montpellier, France)
Behavioural aspect of transgenic Drosophila melanogaster as a model of Parkinson’s disease treated by Ropinirole alginate nanocomposite

F. Naz, R. X, YHS. Siddique (Aligarh, India)
Beliefs, Knowledge and Attitudes Towards Parkinson’s Disease: Turkey Experience from a Global Perspective

Y. Degirmenci, P. Limousin, GM. Hariz, N. Cakar (Duzce, Turkey)
Beneficial and protective effects of Terminalia chebula in a murine model of Parkinson’s disease

A. Kumar, S. Farhat (New Delhi, India)
Beneficial effect of 36-month bilateral subthalamic stimulation on quality of sleep compared to standard-of-care medication in Parkinson’s disease

H. Dafsari, S. Jost, A. Sauerbier, V. Visser-Vandewalle, K. Ashkan, M. Silverdale, J. Evans, P. Löhrer, A. Rizos, JN. Petry-Schmelzer, G. Fink, M. Barbe, A. Antonini, P. Martinez-Martin, K. Ray-Chaudhuri, L. Timmermann (Cologne, Germany)
Beneficial effect of estrogen on nigrostriatal dopaminergic neurons in drug-naïve postmenopausal Parkinson’s disease

YH. Lee, JH. Cha, SJ. Chung, HS. Yoo, YH. Sohn, BS. Ye, PH. Lee (Seoul, Republic of Korea)
Benefit and Weakness with botulinum toxin: time course and relationship.

P. Kassavetis, K. Alter, C. Lungu, B. Karp (Bathesda, MD, USA)
Benign hereditary chorea: A Tunisian family case presentation

M. Akkari, H. Ben Rhouma, H. Klaa, A. Rouissi, I. Kraoua, I. Turki (Tunis, Tunisia)
Beyond the Periphery: Central Auditory Processing in Parkinsonian Disorders

E. de Groote, K. de Keyser, A. Bockstael, D. Botteldooren, P. Santens, M. de Letter (Ghent, Belgium)
Biallelic ZNF142-null mutations in patients with early-onset generalized dystonia

M. Zech, M. Skorvanek, V. Han, P. Dosekova, Z. Gdovinova, M. Wagner, R. Berutti, T. Strom, P. Havránková, A. Fečíková, F. Laccone, R. Jech, J. Winkelmann (Munich, Germany)
Bilateral Globus Pallidum interna stimulation for Blepharospasm

DR. Ginjupally, T. Ali, C. van Horne, Z. Guduru (Lexington, KY, USA)
Bilateral Globus pallidus interna Deep Brain Stimulation in Cranio-Cervical Dystonia (Meige syndrome) patient in Hong Kong

C. Lau, C. Zhu, D. Chan, K. Ma, L. Au, A. Chan, R. Wong, J. Yeung, W. Poon, V. Mok (Hong Kong, Hong Kong)
Bilateral Globus pallidus internus deep brain stimulation as rescue therapy for ineffective subthalamic stimulation

A. Sanchez-Rodriguez, M. Sierra, J. Martino, M. Martinez, R. Roberto, I. Gonzalez Aramburu, J. Infante (Santander, Spain)
Bilateral INO in PSP

H. Gupta (Overland Park, KS, USA)
Bilateral Putaminal AAV2-GDNF Delivery the Treatment of Advanced Parkinson’s Disease

K. Bankiewicz, C. Lungu, D. Hammoud, P. Herscovitch, D. Ehrlich, D. Argersinger, S. Sinharay, G. Scott, T. Wu, W. San Sebastian, V. Suhakar, M. Fiandaca, K. Zaghloul, M. Hallett, R. Lonser, J. Heiss (San Francisco, CA, USA)
Bilateral STN-DBS after bilateral pallidotomy for Parkinson’s disease: A Case Report

CC. Zhang, LB. Wang, DY. Li, BM. Sun (Shanghai, China)
Bilateral vestibulopathy due to neurosarcoidosis mimicking Parkinsonian syndrome

M. Hamaguchi, H. Fujita, K. Suzuki (Utsunomiya, Japan)
Biomarkers of idiopathic REM sleep behavior disorder versus RBD within narcolepsy

E. Antelmi, F. Pizza, Y. Sosero, V. Donadio, A. Incensi, R. Liguori, G. Plazzi (Bologna, Italy)
Biomarkers of the Level of Cognitive Impairment (CI) in patients with Parkinson’s Disease (PD): MRS study

I. Karaban', N. Karasevich, Z. Rozhkova (Kyiv, Ukraine)
Biphasic Dyskinesias in Parkinson’s disease Patients treated with Levodopa/Carbidopa Intestinal Gel: Insights from a Multicenter Retrospective Analysis

M. Marano, T. Naranian, L. Di Biase, A. Di Santo, R. Arca, G. Cossu, P. Marano, V. Di Lazzaro, A. Fasano (Rome, Italy)
Bladder Training for Urinary Tract Symptoms in PD – A Randomised Controlled Trial

C. Mcdonald, J. Rees, K. Winge, J. Newton, D. Burn (Gateshead, United Kingdom)
Blood brain barrier dysfunction cause idiopathic adult onset ventriculomegaly?

E. Oh, H. Chang, S. Kim, S. Kim, J. Heo (Daejeon, Republic of Korea)
Blood Metagenomics Analyses of Brazilian Parkinson’s Disease Patients: A Clinical Substype Study

G. Poralla, V. Rayol, N. Woldmar, B. Fadel, L. Giacomin, A. Rosso, L. Pizzatti (Rio de Janeiro, Brazil)
Blood–brain barrier breakdown in an adult mouse model of Parkinson’s disease

E. Del-Bel, F. Grano (Ribeirão Preto, Brazil)
Blue light therapy glasses in Parkinson’s disease: patients’ experience and effectiveness

K. Smilowska, D. van Wamelen, A. Schoutens, M. Meinders, B. Bloem (Nijmegen, Netherlands)
BODILY AND FACIAL EMOTION RECOGNITION IN PARKINSON´S DISEASE

Z. Kosutzka, P. Brandoburova, I. Straka, V. Veronika, P. Valkovic, M. Hajduk (Bratislava, Slovakia)
Body Mass Gain in Parkinson’s Disease Following Deep Brain Stimulation: A Systematic Review

J. Steinhardt, T. Münte, S. Schmid, B. Wilms, N. Brüggemann (Lübeck, Germany)
Body Representation Impairments in Parkinson’s disease: A Preliminary Report

J. Cardona, C. Martinez, W. Correa, J. Grisales, C. Trujillo, F. Marmolejo-Ramos (Santiago de Cali, Colombia)
Botulinum Neurotoxin (BoNT) treatment in functional movement disorders: an extended follow up

J. Dijk, M. Tijssen, J. Koelman, Y. Dreissen, F. Lambert (Groningen, Netherlands)
Botulinum toxin content and activity: Potential implications for duration of efficacy in patients with cervical dystonia

M. Field, A. Splevins, M. Schans, J. Langenberg, D. Noort, P. Picaut, K. Foster (Rijswijk, Netherlands)
Botulinum toxin for the management of dystonic scoliosis in children

D. Ferman, T. Sanger (Los Angeles, CA, USA)
Botulinum toxin injections reduce the symptoms of dystonic tremor and improve sensorimotor function for hand dexterity

L. Rocchi, A. Latorre, G. Paparella, E. Menozzi, L. Peppoloni, F. Valero-Cuevas, C. Cordivari, K. Bhatia, J. Rothwell (London, United Kingdom)
Botulinum toxin treatment of muscle spasms in a case of Satoyoshi syndrome

I. Bledsoe (San Francisco, CA, USA)
Botulinum toxin type A therapy in a movement disorders unit: a 23-year experience.

M. Velez, C. Cosentino, L. Torres (Lima, Peru)
BouNDless: An active-controlled randomized, double-blind double-dummy study of continuous ND0612 infusion in patients with fluctuating Parkinson’s disease

W. Poewe, K. Kieburtz, F. Stocchi, S. Oren, T. Yardeni, L. Adar, O. Rosenfeld, C. Olanow (Innsbruck, Austria)
Braak model in Parkinson disease using MRI biomarkers

N. Pyatigorskaya, L. Yahia-Cherif, R. Valabregue, R. Gaurav, M. Mongin, C. Ewenczyk, C. Gallea, F. Gargouri, E. Bardinet, I. Arnulf, M. Vidailhet, S. Lehericy (Paris, France)
Brain amyloid contribution to cognitive dysfunction in Lewy bodies disorders: a pilot study

R. Biundo, E. Fiorenzato, D. Cecchin, C. Salvotti, L. Weis, A. Antonini (Venice, Italy)
Brain and spinal cord structural alterations in non-ataxic and ataxic SCA3 mutation carriers

J. Faber, I. Giordano, B. Koyak, R. Wolz, S. Romanzetti, MC. Franca Jr, H. Jiang, A. Durr, B. Bender, J. Diedrichsen, T. Klockgether (Bonn, Germany)
Brain MRI Volume Changes after 12 months laquinimod treatment of Huntington disease (LEGATO-HD)

R. Reilmann, M. Gordon, A. Feigin, K. Anderson, S. Tabrizi, B. Leavitt, J. Stout, P. Piccini, N. Hobbs, R. Manber, B. Borowsky, G. Rynkowski, R. Volkinshtein, J. Savola, M. Hayden (Victoria, Australia)
Brain MRI-based discrimination between multiple system atrophy type cerebellar from other late onset sporadic cerebellar ataxias: a prospective study with implications for diagnosis criteria

G. Carré, JL. Dietemann, O. Gebus, S. Montaut, O. Lagha-Boukbiza, T. Wirth, S. Kremer, IJ. Namer, M. Anheim, C. Tranchant (Strasbourg, France)
Brain neurotransmitters and neuropeptides alternations in Parkinson’s induced mouse models

N. Kumar, R. Khanna (Jaipur, India)
BST1 rs4698412 allelic variant increases the risk of gait or balance deficits in patients with Parkinson’s disease

Y. Shen, J. Wang, K. Zhang (Nanjing, China)
Bumetanide to treat Parkinson’s disease patients suffering from freezing of gait resistant to both dopamine replacement treatment and subthalamic deep brain stimulation: an open-label pilot study (BumFOG)

P. Damier, W. Kamel, J. Al Hashel (Kuwait, Kuwait)
Burden of Huntington’s disease in the US: Analysis of an insured population

K. Raimundo, J. Luo, R. Tan, T. To, R. Fuller, J. Warner (South San Francisco, CA, USA)